Health ❯ Medicine

Pharmaceuticals

Weight Loss Drug Development Clinical Trials Weight Loss Drugs Diabetes Acetaminophen Pain Relief Drug Approval Drug Safety Cannabis

Doctors Outline Safe Use of Peptides as FDA Weighs Easing Restrictions

Experts warn many popular peptides lack solid trials, with sourcing risks from online sellers.

New Photos Show Discoloration on Both of Trump’s Hands, Reviving Health Questions

HHS Push to Ease Peptide Curbs Spurs FDA Review and Investor Bets

Largest Danish Study Finds No Autism Risk From Acetaminophen Use in Pregnancy

Experimental Drug Elraglusib Extends Survival in Phase 2 Pancreatic Cancer Trial

FDA Grants Orphan Drug Status to Immutep’s Efti for Soft Tissue Sarcoma

Amazon Pharmacy Launches Same-Day Delivery for Lilly’s Foundayo Weight-Loss Pill

Iran War Chokes Gulf Routes, UK Warned of Medicine Shortages Within Weeks

AstraZeneca’s COPD Antibody Tozorakimab Succeeds in Two Phase 3 Trials

Novartis Strikes $2 Billion Deal for Mutant-Selective PI3Kα Cancer Drug SNV4818

Structure’s Oral Obesity Pill Delivers 16.3% Placebo-Adjusted Weight Loss in Phase 2

FDA Approves Leucovorin for Ultra-Rare FOLR1 Folate Disorder, Declines Autism Indication

Xenon to Present Topline X-TOLE2 Phase 3 Results in Focal Onset Seizures at 8 A.M. ET Today

On Jan Aushadhi Diwas, Modi Hails Low-Cost Drug Network as Government Sets Sights on 25,000 Kendras by 2027

EMA Backs Single-Dose Acoziborole for Gambiense Sleeping Sickness Outside EU

Cochrane Review Finds No Clear Benefit From Daily Aspirin for Colorectal Cancer Prevention

UAE Orders Multiple Authorised Agents Per Medicine to Curb Drug Monopolies

Novo Nordisk to Cut U.S. List Prices for Wegovy, Ozempic and Rybelsus to $675 in 2027

GSK to Acquire 35Pharma for $950 Million to Add Pulmonary Hypertension Candidate HS235

Novo’s Triple-Hormone Obesity Drug UBT251 Hits 19.7% Mean Weight Loss in China Phase 2